These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 28272135)

  • 1. The adherence gap: a longitudinal examination of men's and women's antiretroviral therapy adherence in British Columbia, 2000-2014.
    Puskas CM; Kaida A; Miller CL; Zhang W; Yip B; Pick N; Montaner JS; Hogg RS
    AIDS; 2017 Mar; 31(6):827-833. PubMed ID: 28272135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with antiretroviral medication adherence among HIV-positive adults accessing highly active antiretroviral therapy (HAART) in British Columbia, Canada.
    O'Neil CR; Palmer AK; Coulter S; O'Brien N; Shen A; Zhang W; Montaner JS; Hogg RS
    J Int Assoc Physicians AIDS Care (Chic); 2012; 11(2):134-41. PubMed ID: 22318879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sub-optimal adherence to combination anti-retroviral therapy and its associated factors according to self-report, clinician-recorded and pharmacy-refill assessment methods among HIV-infected adults in Addis Ababa.
    Mekuria LA; Prins JM; Yalew AW; Sprangers MA; Nieuwkerk PT
    AIDS Care; 2017 Apr; 29(4):428-435. PubMed ID: 27701908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower Optimal Treatment Adherence Among Youth Living With HIV in a Universal Health Care Setting Where ART Is Available at No Cost.
    Closson K; Palmer A; Salters K; Puskas C; Parashar S; Tiamiyu L; Zhang W; Barrios R; Kaida A; Hogg RS
    J Adolesc Health; 2019 Apr; 64(4):509-515. PubMed ID: 30545583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Female gender predicts lower access and adherence to antiretroviral therapy in a setting of free healthcare.
    Tapp C; Milloy MJ; Kerr T; Zhang R; Guillemi S; Hogg RS; Montaner J; Wood E
    BMC Infect Dis; 2011 Apr; 11():86. PubMed ID: 21466704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
    Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS
    Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Migration adversely affects antiretroviral adherence in a population-based cohort of HIV/AIDS patients.
    Lima V; Fernandes K; Rachlis B; Druyts E; Montaner J; Hogg R
    Soc Sci Med; 2009 Mar; 68(6):1044-9. PubMed ID: 19157668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV Suppression.
    Castillo-Mancilla JR; Brown TT; Erlandson KM; Palella FJ; Gardner EM; Macatangay BJ; Breen EC; Jacobson LP; Anderson PL; Wada NI
    Clin Infect Dis; 2016 Dec; 63(12):1661-1667. PubMed ID: 27660234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal trends of HIV drug resistance in a large Canadian cohort, 1996-2016.
    Rocheleau G; Brumme CJ; Shoveller J; Lima VD; Harrigan PR
    Clin Microbiol Infect; 2018 Feb; 24(2):185-191. PubMed ID: 28652115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Pill Burden on Adherence, Risk of Hospitalization, and Viral Suppression in Patients with HIV Infection and AIDS Receiving Antiretroviral Therapy.
    Scott Sutton S; Magagnoli J; Hardin JW
    Pharmacotherapy; 2016 Apr; 36(4):385-401. PubMed ID: 26923931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
    Roux P; Fugon L; Winnock M; Salmon-Céron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP;
    Addiction; 2012 Jan; 107(1):152-9. PubMed ID: 21819472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors linked to transitions in adherence to antiretroviral therapy among HIV-infected illicit drug users in a Canadian setting.
    Joseph B; Kerr T; Puskas CM; Montaner J; Wood E; Milloy MJ
    AIDS Care; 2015; 27(9):1128-36. PubMed ID: 25915438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe menopausal symptoms associated with reduced adherence to antiretroviral therapy among perimenopausal and menopausal women living with HIV in Metro Vancouver.
    Duff PK; Money DM; Ogilvie GS; Ranville F; Kestler M; Braschel MC; Pick N; Shannon K;
    Menopause; 2018 May; 25(5):531-537. PubMed ID: 29206769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the impact of food insecurity on HIV medication adherence in the context of an integrated care programme for people living with HIV in Vancouver, Canada.
    Koehn K; McLinden T; Collins AB; McDougall P; Baltzer-Turje R; Miewald C; Wang L; Li J; Salters KA; Hogg RS; Parashar S
    Public Health Nutr; 2020 Mar; 23(4):683-690. PubMed ID: 31507259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
    Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E
    Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Social-structural factors associated with supportive service use among a cohort of HIV-positive individuals on antiretroviral therapy.
    O'Brien N; Palmer AK; Zhang W; Michelow W; Shen A; Roth E; Rhodes CL; Salters KA; Montaner JS; Hogg RS
    AIDS Care; 2013 Aug; 25(8):937-47. PubMed ID: 23320437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Barriers to Antiretroviral Therapy Among Sex Workers Living with HIV: Findings of a Longitudinal Study in Vancouver, Canada.
    Goldenberg SM; Montaner J; Duff P; Nguyen P; Dobrer S; Guillemi S; Shannon K
    AIDS Behav; 2016 May; 20(5):977-86. PubMed ID: 26148850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Utility of Pharmacy-Based Adherence Measurement in Predicting Virologic Outcomes in an Adult HIV-Infected Cohort in Jos, North Central Nigeria.
    Abah IO; Ojeh VB; Musa J; Ugoagwu P; Agaba PA; Agbaji O; Okonkwo P
    J Int Assoc Provid AIDS Care; 2016; 15(1):77-83. PubMed ID: 24963086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of gender and calendar year on time to and duration of virologic suppression among antiretroviral-naïve HIV-infected individuals initiating combination antiretroviral therapy.
    Raboud J; Blitz S; Walmsley S; Thompson C; Rourke SB; Loutfy MR;
    HIV Clin Trials; 2010; 11(6):340-50. PubMed ID: 21239362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.